article thumbnail

FDA Outlines Considerations for Conducting Clinical Investigations Using Psychedelic Drugs

Hall Render

In June 2023, the Food and Drug Administration (“FDA”) released Draft Guidance outlining its current view of the psychedelic research landscape. While the FDA does not define psychedelics, it indicated that the shorthand term “psychedelic” includes “classic psychedelics,” which are typically understood to be 5-HT2 agonists (e.g.,

FDA 40
article thumbnail

Microdosing at Work: Business and Legal Implications

Bill of Health

The Food and Drug Administration has authorized studies of psychedelics , including on a “breakthrough therapy” designation, but these drugs may not be handled by persons without a Drug Enforcement Administration license and outside an FDA approved setting. Or a specific ban on microdosing, inside or outside of work hours?

Licensing 293
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare Supplier Compliance Checklist

MedTrainer

WEBINAR: Presenting Compliance Information To Your Board or Executive Team Watch Now What Should Be on Your Supplier Compliance Checklist? For example, a healthcare IT vendor should include items related to HIPAA, while a checklist for a food vendor should focus on FDA or USDA regulations.

article thumbnail

Digital Health in the Metaverse: Three Legal Considerations

Healthcare Law Blog

These advancements, present challenges and raise novel questions as to how the current healthcare and life sciences legal regime would apply to the metaverse. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Data Privacy and Security. 1, 2021). [2]

FDA 90
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

Together, these articles underscore the injustice of the present moment and emphasize the need to reform intellectual property protections for government-funded inventions of public health significance. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

article thumbnail

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

Health Care Law Brief

For example, New York continues to maintain a professional licensing waiver that enables certain providers, licensed out of state, to render care within the state, for the duration of the declared state of emergency. Variety of Risks Present in Telehealth Arrangements. Provider Licenses.

article thumbnail

How Should RPM Vendors Choose Remote Patient Monitoring Device Suppliers?

Healthcare IT Today

They purchase the technical solutions such as algorithms and software licenses with no R&D or engineering capabilities on staff. RPM devices work as medical devices which are governed by the FDA and related departments. Principle 2: Evaluate the regulation competence of the suppliers. There were not any outside connections.

FDA 89